(Q44484802)

3 December 2017

title

Characterization of etoricoxib, a novel, selective COX-2 inhibitor (English)

1 reference

3 December 2017

Aimee Dallob

1

1 reference

3 December 2017

Christopher J Hawkey

2

1 reference

3 December 2017

Howard Greenberg

3

1 reference

3 December 2017

Nicholas Wight

4

1 reference

3 December 2017

Paul De Schepper

5

1 reference

3 December 2017

Scott Waldman

6

1 reference

3 December 2017

Peggy Wong

7

1 reference

3 December 2017

Lisa DeTora

8

1 reference

3 December 2017

Barry Gertz

9

1 reference

3 December 2017

Nancy Agrawal

10

1 reference

3 December 2017

John Wagner

11

1 reference

3 December 2017

Keith Gottesdiener

12

1 reference

3 December 2017

publication date

1 June 2003

1 reference

The Journal of Clinical Pharmacology

3 December 2017

published in

1 reference

3 December 2017

volume

43

1 reference

3 December 2017

issue

6

1 reference

3 December 2017

page(s)

573-585

1 reference

Human cyclooxygenase-2 cDNA

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253703

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253703

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253703

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253703

Review article: the gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253703

Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253703

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253703

A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253703

Single- and multiple-dose pharmacokinetics of etoricoxib, a selective inhibitor of cyclooxygenase-2, in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253703

In vitro metabolism considerations, including activity testing of metabolites, in the discovery and selection of the COX-2 inhibitor etoricoxib (MK-0663).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253703

The coxibs, selective inhibitors of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253703

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253703

Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: A randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253703

Effect of ibuprofen on cardioprotective effect of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253703

Cyclooxygenase-1 and Cyclooxygenase-2 Selectivity of Widely Used Nonsteroidal Anti-Inflammatory Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003253703

21 January 2018

Identifiers

DOI

10.1177/0091270003253703

1 reference

3 December 2017

1 reference